Chemir Analytical Services has launched IQsynthesis, formerly known as Gateway Chemical Technology, Inc. Chemir acquired Gateway Chemical Technology, which provides custom synthesis and process development services, in May 2006.
Chemir Launches IQsynthesis
Patricia Van Arnum
St. Louis, MO (Sept. 15)-Chemir Analytical Services (Maryland Heights, MO, www.chemir.com) has launched IQsynthesis (www.IQsynthesis.com), formerly known as Gateway Chemical Technology, Inc. Chemir acquired Gateway Chemical Technology, which provides custom synthesis and process development services, in May 2006.
“Clients have been requesting synthetic chemistry services, and we sought an acquisition to best fill this need,” explains Shri Thanedar, CEO of Chemir Analytical Services.
IQsynthesis offers synthesis services for pharmaceutical intermediates; bioorganic compounds; and specialty, fine, and agrochemicals. Other services include synthesis of analytical standards, metabolites, tox lot batches, stable isotope-labeled compounds, intermediates, custom surfactants, combinational platforms, extraction and purification of natural products, and process development. Plans are underway to expand laboratory space and staff as well as develop infrastructure and systems for CGMP-regulated synthesis.
The Chemir group of companies include IQsynthesis; Chemir Analytical Services; Azopharma, a pharmaceutical contract service provider; and CAS-MI, a laboratory serving the paints, coatings, and polymer industries. Total sales for the company are expected to reach $24 million in 2006, with an anticipated goal of reaching $50 million by 2009.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.